NOVEMBER 13, 2019, New York- Ludwig Cancer Research congratulates Ping-Chih Ho on his selection by the European Molecular Biology Association (EMBO) as a member of its Young Investigator Programme. The program recognizes Europe’s most promising researchers under the age of 40 who have recently established independent laboratories and provides them practical and financial support essential to this period of their careers.
A researcher at the Lausanne Branch of the Ludwig Institute for Cancer Research, Ho is a leader in the young field of immunometabolism, which explores how the chemical byproducts of metabolism mediate a molecular conversation between the immune system and the tissues it patrols. That conversation has a profound influence on tumor growth and survival and on the efficacy of conventional and immunotherapeutic interventions for the treatment of cancer. Ho’s laboratory has recently made important contributions to our understanding of how immunometabolomic effects alter the behavior of immune cells like macrophages and dendritic cells in tumors and disrupt the T cell response to cancer that is essential to immunotherapy.
Ho joined Ludwig Lausanne in 2015, following a postdoctoral appointment in the laboratory of Susan Kaech, who was then at Yale University and with whom he conducted pioneering research in the field. In addition to his Ludwig post, Ho is a tenured associate professor at the University of Lausanne.
